Search

Iron oxide nanoparticles (MNPs) demonstrate notable benefits in magnetic induction, attributed to their distinctive physical and chemical attributes. Emerging cancer treatment utilizing magnetic fields have also gathered increasing attention in the biomedical field. However, the defects of difficult dispersion and poor biocompatibility of MNPs seriously hinder their application. In order to overcome its inherent defects and maximize the therapeutic potential of MNPs, various functionalized MNPs have been developed, and numerous combined treatment methods based on MNPs have been widely studied. In this review, we compare and analyze the common nanoparticles based on MNPs with different sizes, shapes, and functional modifications. Additionally, we introduced the therapeutic mechanisms of the strategies, such as magnetically controlled targeting, magnetic hyperthermia, and magneto‐mechanical effect, which based on the unique magnetic induction capabilities of MNPs. Finally, main challenges of MNPs as smart nanomaterials were also discussed. This review seeks to offer a thorough overview of MNPs in biomedicine and a new sight for their application in tumor treatment. [ABSTRACT FROM AUTHOR]

Iron oxide nanocubes (IONCs) are among the most promising materials in magnetic hyperthermia (MHT) for tumor therapy as they can efficiently convert magnetic energy into heat under alternating magnetic field (AMF). Conventional IONCs syntheses  are based on thermal decomposition methods, limited by the long reaction time (hours) and milligram‐scale production; while, solvothermal methods produce gram‐scale amount of high quality IONCs, but, reaction times are of the orders of hours. In this work, a microwave‐assisted route to shape‐control IONCs in which the reaction time is reduced to minutes while achieving a high iron conversion yield up to 80% is reported. The size of the IONCs (range 13–30 nm) is coarse‐tuned by adjusting the amount of benzaldehyde ligand, while fine‐size tuning is achieved by changing temperature and minute‐reaction time. IONCs exhibit superparamagnetic behavior at 298 K with saturation magnetization over 80 emu gIONC−1 and possess high specific absorption rate values (SAR) up to 400 W gFe−1 at clinical AMF conditions. These results mark a milestone for rapid synthesis of IONCs at high yield conversion of well‐defined size and shape nanocubes with benchmark MHT heat performance while using a fast route, with limited energy consumption which makes this method greener and cheaper than previous ones. [ABSTRACT FROM AUTHOR]

Introduction: The development of magnetic agents for magnetic fluid hyperthermia application is a complex task requiring simultaneous optimization of chemical, biomedical, magnetic, and, in particular, thermal properties of magnetic nanoparticles (MNPs). In the majority of papers, the magnetothermal measurements are carried out on bare MNPs suspended in deionized water with subsequent optimization of the required physiological and medical properties, including toxicity and biocompatibility. However, in real hyperthermia practice, the stable fluids or colloids of magnetic MNPs are used, and the colloidal stabilization can significantly modify their magnetic properties, including magnetothermal ones. Methods: This paper is focused on the study of Zn x Mn1- x Fe2O4 MNPs stabilized by oleic acid/sodium oleate in this context. Results and Discussion: Our research demonstrates the crucial changes in the magnetic properties and magnetothermal response of ZnMn ferrite MNPs after the colloidal stabilization: while bare MNPs demonstrate significant coercivity, nonzero remanent magnetization, and superquadratic dependence of heat generation on the magnetic field amplitude, the magnetic properties of colloidal ZnMn ferrite MNPs are typical for superparamagnetic ones and their magnetothermal response is described by a conventional quadratic dependence on magnetic field amplitude. Various factors such as size distribution, magnetic anisotropy, and interparticle dipole–dipole interaction are considered as the origins of such an impact on magnetic MNPs' properties. [ABSTRACT FROM AUTHOR]

This study aims to describe and evaluate the performance of a new device for magnetic hyperthermia that can produce an alternating magnetic field with adjustable frequency without the need to change capacitors from the resonant bank, as required by other commercial devices. This innovation, among others, is based on using a capacitator bank that dynamically adjusts the frequency. To validate the novel system, a series of experiments were conducted using commercial magnetic nanoparticles (MNPs) demonstrating the device's effectiveness and allowing us to identify new challenges associated with the design of more powerful devices. A computational model was also used to validate the device and to allow us to determine the best system configuration. The results obtained are consistent with those from other studies using the same MNPs but with magnetic hyperthermia commercial equipment, confirming the good performance of the developed device (e.g., consistent SAR values between 1.37 and 10.80 W/gMNP were obtained, and experiments reaching temperatures above 43 °C were also obtained). This equipment offers additional advantages, including being economical, user-friendly, and portable. [ABSTRACT FROM AUTHOR]

Background/Objectives: Magnetic nanoparticles (MNPs) have gained attention in theranostics for their ability to combine diagnostic imaging and therapeutic capabilities in a single platform, enhancing targeted treatment and monitoring. Surface coatings are essential for stabilizing MNPs, improving biocompatibility, and preventing oxidation that could compromise their functionality. Natural rubber latex (NRL) offers a promising coating alternative due to its biocompatibility and stability-enhancing properties. While NRL-coated MNPs have shown potential in applications such as magnetic resonance imaging, their effectiveness in theranostics, particularly magnetic hyperthermia (MH) and photoacoustic imaging (PAI), remains underexplored. Methods: In this study, iron oxide nanoparticles were synthesized via coprecipitation, using NRL as the coating agent. The samples were labeled by NRL amount used during synthesis: NRL-100 for 100 μL and NRL-400 for 400 μL. Results: Characterization results showed that NRL-100 and NRL-400 samples exhibited improved stability with zeta potentials of −27 mV and −30 mV, respectively and higher saturation magnetization values of 79 emu/g and 88 emu/g of Fe3O4. Building on these findings, we evaluated the performance of these nanoparticles in biomedical applications, including magnetomotive ultrasound (MMUS), PAI, and MH. NRL-100 and NRL-400 samples showed greater displacements and higher contrast in MMUS than uncoated samples (5, 8, and 9 µm) at 0.5 wt%. In addition, NRL-coated samples demonstrated an improved signal-to-noise ratio (SNR) in PAI. SNR values were 24.72 (0.51), 31.44 (0.44), and 33.81 (0.46) dB for the phantoms containing uncoated MNPs, NRL-100, and NRL-400, respectively. Calorimetric measurements for MH confirmed the potential of NRL-coated MNPs as efficient heat-generating agents, showing values of 43 and 40 W/g for NRL-100 and NRL-400, respectively. Conclusions: Overall, NRL-coated MNPs showed great promise as contrast agents in MMUS and PAI imaging, as well as in MH applications. [ABSTRACT FROM AUTHOR]

The present study reveals the synthesis of Iron oxide nanoparticles (IONPs) by varying the molar ratio of ferric (Fe3+) to ferrous (Fe2+) ions via chemical coprecipitation method for the study of cationic distribution of Fe‐ions and its potential application for magnetic hyperthermia therapy (MHT). X‐ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), and X‐ray photoelectron spectroscopy (XPS), were used to characterize the physicochemical properties. Several structural parameters were estimated using the Rietveld refinement, resulting in structural modelling verified by magnetic characteristics. A vibrating sample magnetometer (VSM) assessed the magnetic hysteresis loop at room temperature in a field range of ±15 kOe, revealing superparamagnetic behavior for the ratio Fe2+/Fe3+ 1:2. The saturation magnetization (Ms) of IONPs increased with the increasing Fe2+ concentration and attained a maximum value of 60.21 emu g−1 at a molar ratio of 2:1. The potential of the inductive heating capability of IONPs in an alternating current magnetic field (AMF) was studied to treat localized MHT. The changes in magnetic properties and inductive heating properties of IONPs are associated with the cationic distribution of Fe2+ at the tetrahedral (A) and octahedral (B) sites of crystal structure. The variation in cationic properties at the A and B sites may result in varying/tuneable magnetic properties, affecting the overall heating profiles of hyperthermia. [ABSTRACT FROM AUTHOR]

Magnetic particle imaging (MPI) is an emerging modality that can address longstanding technological challenges encountered with magnetic particle hyperthermia (MPH) cancer therapy. MPI is a tracer technology compatible with MPH for which magnetic nanoparticles (MNPs) provide signal for MPI and heat for MPH. Identifying whether a specific MNP formulation is suitable for both modalities is essential for clinical implementation. Current models predict that functional requirements of each modality impose conflicting demands on nanoparticle magnetic properties. This objective here is to develop a measurement and ranking scheme based on end‐use performance to streamline evaluation of candidate MNP formulations. The measured MPI point‐spread function (PSF) and specific loss power (SLP) is combined to generate a single numerical value for comparison on a relative ranking scale, or figure of merit (FoM). 12 aqueous iron‐containing formulations are evaluated, including FDA‐approved (parenteral) iron‐containing colloids. MNPs with high (Synomag‐D70: 123.4), medium (Synomag‐D50: 63.2), and low (NanoXact: 0.147) FoM values are selected for in vivo validation of the selection scheme in subcutaneous 4T1 tumors. Results demonstrate that the proposed ranking accurately assessed the relative performance of MNPs for MPI and MPH. Data demonstrated that image quality and tumor temperature rise increased with FoM ranking, validating predictions. It isshown that the MPI signal correlated with MNP concentration in tissue. Computational heat transfer models anchored on tumor MPI data harmonized with experimental results to within an average of 2 °C when MNP content estimated from MPI data is included. Computational studies emphasized the importance of post‐injection MNP quantitation and MPI spatial resolution. [ABSTRACT FROM AUTHOR]

Background: Magnetic hyperthermia (MHT) has emerged as a promising therapeutic approach in the field of radiation oncology due to its superior precision in controlling temperature and managing the heating area compared to conventional hyperthermia. Recent studies have proposed solutions to address clinical safety concerns associated with MHT, which arise from the use of highly concentrated magnetic nanoparticles and the strong magnetic field needed to induce hyperthermic effects. Despite these efforts, challenges remain in quantifying therapeutic outcomes and developing treatment plan systems for combining MHT with radiation therapy (RT). Purpose: This study aims to quantitatively measure the therapeutic effect, including radiation dose enhancement (RDE) in the magnetic hyperthermia‐radiation combined therapy (MHRT), using the equivalent radiation dose (EQD) estimation method. Methods: To conduct EQD estimation for MHRT, we compared the therapeutic effects between the conventional hyperthermia‐radiation combined therapy (HTRT) and MHRT in human prostate cancer cell lines, PC3 and LNCaP. We adopted a clonogenic assay to validate RDE and the radiosensitizing effect induced by MHT. The data on survival fractions were analyzed using both the linear‐quadradic model and Arrhenius model to estimate the biological parameters describing RDE and radiosensitizing effect of MHRT for both cell lines through maximum likelihood estimation. Based on these parameters, a new survival fraction model was suggested for EQD estimation of MHRT. Results: The newly designed model describing the MHRT effect, effectively captures the variations in thermal and radiation dose for both cell lines (R2 > 0.95), and its suitability was confirmed through the normality test of residuals. This model appropriately describes the survival fractions up to 10 Gy for PC3 cells and 8 Gy for LNCaP cells under RT‐only conditions. Furthermore, using the newly defined parameter r, the RDE effect was calculated as 29% in PC3 cells and 23% in LNCaP cells. EQDMHRT calculated through this model was 9.47 Gy for PC3 and 4.71 Gy for LNCaP when given 2 Gy and MHT for 30 min. Compared to EQDHTRT, EQDMHRT showed a 26% increase for PC3 and a 20% increase for LNCaP. Conclusions: The proposed model effectively describes the changes of the survival fraction induced by MHRT in both cell lines and adequately represents actual data values through residual analysis. Newly suggested parameter r for RDE effect shows potential for quantitative comparisons between HTRT and MHRT, and optimizing therapeutic outcomes in MHRT for prostate cancer. [ABSTRACT FROM AUTHOR]

Integrating hyperthermia with conventional cancer therapies shows promise in improving treatment efficacy while mitigating their side effects. Nanotechnology-based hyperthermia, particularly using superparamagnetic iron oxide nanoparticles (SPIONs), offers a simplified solution for cancer treatment. In this study, we developed composites of SPION quantum dots (Fe3O4) with reduced graphene oxide (Fe3O4/RGO) using the coprecipitation method and investigated their potential application in magnetic hyperthermia. The size of Fe3O4 nanoparticles was controlled within the quantum dot range (≤10 nm) by varying the synthesis parameters, including reaction time as well as the concentration of ammonia and graphene oxide, where their biocompatibility was further improved with the inclusion of polyethylene glycol (PEG). These nanocomposites exhibited low cytotoxic effects on healthy cells (CHO-K1) over an incubation period of 24 h, though the inclusion of PEG enhanced their biocompatibility for longer incubation periods over 48 h. The Fe3O4/RGO composites dispersed in acidic pH buffer (pH 4.66) exhibited considerable heating effects, with the solution temperature increasing by ~10 °C within 5 min of exposure to pulsed magnetic fields, as compared to their dispersions in phosphate buffer and aqueous dimethylsulfoxide solutions. These results demonstrated the feasibility of using quantum dot Fe3O4/RGO composites for magnetic hyperthermia-based therapy to treat cancer, with further studies required to systematically optimize their magnetic properties and evaluate their efficacy for in vitro and in vivo applications. [ABSTRACT FROM AUTHOR]

Breast cancer is one of the deadliest cancers for women, so cell labeling and therapy of breast cancer become imperative. In this work, dextran- and carboxymethyl dextran–coated Fe3O4 nanoparticles (Fe3O4@DEX and Fe3O4@CMD) were well synthesized through the co-precipitation method. The dextran and carboxymethyl dextran coating reduces the average particle size of Fe3O4 nanoparticles from 10.9 to 4.0–5.5 nm, and the coated samples exhibit average hydrodynamic diameters ranging from 31 to 110 nm. The coating promotes the dispersibility of nanoparticles. Saturation magnetization is reduced from 60.3 to 5.6–7.1 emu/g in the coated MNPs due to the large weight ratio of the coating layer and the decrease in particle size. Hemolysis and cytotoxicity assay results indicate the excellent biocompatibility of Fe3O4 nanoparticles. The cellular uptake assay confirms that both dextran- and carboxymethyl dextran–coated Fe3O4 nanoparticles are easily taken in by breast cancer cells. Comprehensively considering dispersion, biocompatibility, and cellular uptake, the Fe3O4@CMD is more suitable for application in the bio-labeling of breast cancer cells. The SAR values of the Fe3O4@DEX and Fe3O4@CMD range from 19.2 to 30.7 W/g. The SAR value is mainly influenced by the hydrodynamic diameter in the coated samples. The Fe3O4@CMD20 shows the maximum SAR value of 30.7 W/g and has potential application in magnetic hyperthermia therapy. [ABSTRACT FROM AUTHOR]

Objectives: Although magnetically induced hyperthermia has shown great efficiency in the treatment of solid tumors, it is still a challenge to avoid incomplete ablation or overtreatment. In this study, we applied magnetomotive ultrasound shear wave elastography (MMUS‐SWE) as a tool for real‐time image guidance and feedback in the magnetic hyperthermia (MH) process. We called this new method as magneto‐acoustic theranostic approach (MATA). Methods: In MATA, a ferromagnetic particle (fMP) was simultaneously used as a thermoseed for MH and a shear wave source for MMUS‐SWE. The fMP was excited by a high‐frequency magnetic field to induce the heating effect for MH. Meanwhile, the fMP was stimulated by a pulsed magnetic field to generate shear wave propagation for MMUS‐SWE. Thus, the changes in elastic modulus surrounding fMP can be used to estimate the therapy effect of MH. Results: The phantom and in vitro experiments were conducted to verify the feasibility of MATA, which has good performance in magnetothermal conversion and treatment efficacy feedback. The shear wave speed of the isolated pork liver changed significantly after the MH process, which varied from about 1.36 to 4.85 m/s. Conclusions: Preliminary results proved that changes in elastic modulus could be useful to estimate the therapy effect of MH. We expect that MATA, which is the integration of MMUS‐SWE and MH, will be a novel theranostic method for clinical translation. [ABSTRACT FROM AUTHOR]

Recently, cubic ferrites (CFs) have been widely explored in biomedical applications, especially those that display superparamagnetism behavior due to the desirable absence of a remanent field. In this study, we report the self-stabilization of the magnetic fluid hyperthermia (MFH) temperature in the cancer therapy range (42–48 °C) by Ce3+ substitution in superparamagnetic Mn0.8Zn0.2Fe2-xCexO4 ferrite particles with x = 0.0; 0.015; 0.030; 0.050 and 0.100. A comprehensive characterization was performed in order to investigate the influence of this replacement on the magnetic and structural properties of the ferrite. The samples were synthesized by the sol-gel auto-combustion method and the properties were characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), selected area electron diffraction (SAED), Raman spectroscopy (RS), Mössbauer spectroscopy (MS), vibrational sample magnetometry (VSM), and ferromagnetic resonance (FMR). Magnetic hyperthermia essays were used to obtain the heat induction curves and calculate energy dissipation. We refined the XRD data by the Rietveld method to determine the cation distribution and calculate interionic parameters. Magnetic characterization confirms the superparamagnetic behavior at 300 K, which is expected from the TEM results that show a narrow distribution of particle sizes, with a mean size of about 6 nm for all samples. The VSM results show a consistent decrease in magnetization saturation with cerium content that leads to a weaker self-heating induction capacity for the cerium-doped samples. FMR results show a smaller relaxation time T2 for these samples, suggesting a slower energy dissipation rate. These conclusions are confirmed by the heat induction curves and the values of the specific absorption rate (SAR), which are smaller for cerium-doped samples. For themagnetic field with an amplitude of 35.33 kA/m and a frequency of 222 kHz, the temperature of the cerium-doped samples saturates in the optimum interval for cancer treatment, between 42 and 48 °C. These results suggest that Ce3+ is a promising doping ion to optimize the heating rate behavior of Mn–Zn ferrite for cancer treatment by hyperthermia.

Abstract Most of published research on magnetic hyperthermia focused on iron oxides, ferrites, and binary alloy nanostructures, while the ternary alloys attracted much limited interest. Herein, we prepared NiCuCo ternary alloy nanocomposites with variable compositions by mechanical alloying. Physical properties were fully characterized by XRD, Rietveld analysis, XPS, SEM/EDX, TEM, ZFC/FC and H-M loops. DFT calculations were used to confirm the experimental results in terms of structure and magnetism. The results showed that the fabricated nanoalloys are face centered cubic (FCC) with average core sizes of 9–40 nm and behave as superparamagnetic with saturation in the range 4.67–42.63 emu/g. Langevin fitting corroborated the superparamagnetic behavior, while law of approach to saturation (LAS) was used to calculate the magnetic anisotropy constants. Heating effciencies were performed under an alternating magnetic field (AMF, H0 = 170 Oe and f = 332.5 kHz), and specific absorption rate (SAR) values were determined. The highest magnetic saturation (Ms), heating potentials, and SAR values were attained for Ni35Cu30Co35 containing the lowest Cu but highest Ni and Co percentages, and the least for Ni15Cu70Co15. Importantly, the nanoalloys reached the required temperatures for magnetic hyperthermia (42 °C) in relatively short times. We also showed that heat dissipiation can be simply tuned by changing many parameters such as concentration, field amplitude, and frequency. Finally, cytotoxicity viability assays against two different breast cancer cell lines treated with Ni25Cu50Co25 nanoalloy in the presence and absence of AMF were investigated. No significant decrease in cancer cell viability was observed in the absence of AMF. When tested against tumorigenic KAIMRC2 breast cancer cells under AMF, the NiCuCo nanoalloy was found to be highly potent to the cells (~ 2-fold enhancement), killing almost all the cells in short times (20 min) and clinically-safe AC magnetic fields. These findings strongly suggest that the as-prepared ternary NiCuCo nanoalloys hold great promise for potential magnetically-triggered cancer hyperthermia.

Combining hyperthermia and chemotherapy for maximum anticancer efficacy remains a challenge because drug-tolerant cancer cells often evade this synergistic treatment due to drug resistance and asynchronous drug release. In this study, multifunctional scaffolds were designed to efficiently treat drug-tolerant breast cancer by improving the sensitization of breast cancer cells and synchronizing anticancer drug release with magnetic hyperthermia. The scaffolds contained microRNA-encapsulated matrix metalloproteinase-cleavable liposomes, doxorubicin-encapsulated thermoresponsive liposomes and Fe3O4 nanoparticles. The scaffolds could release microRNA specifically to improve the sensitization of breast cancer cells to anticancer drugs. The scaffolds also showed excellent hyperthermia effects under alternating magnetic field irradiation. Moreover, doxorubicin release was synchronized with magnetic hyperthermia. In vitro and in vivo studies demonstrated that the scaffolds effectively reduced drug resistance and eliminated doxorubicin-tolerant MDA-MB-231 cells through the synergistic effect of magnetic hyperthermia and sensitizing chemotherapy. Additionally, the scaffolds could support the proliferation and adipogenic differentiation of stem cells for adipose tissue regeneration after killing cancer cells at a late therapeutic stage. These composite scaffolds offer an innovative strategy for treating breast cancer, with synergistic anticancer effects and regenerative functions.

One of the hallmarks of tissue repair is the production of reactive oxygen species (ROS), which modulate processes such as cell proliferation. Although several attempts have been made to manipulate ROS levels to increase tissue repair, the lack of techniques able to remotely manipulate the redox homeostasis with spatio–temporal fashion has hindered its progress. Herein, a new approach for tuning the ROS levels using magnetic nanoparticles (MNPs) that act as nanoheaters when exposed to an alternating magnetic field is presented. Two manganese–iron oxide (MnxFe3−xO4) MNPs (with a low and a high Mn2+ content) are designed and probed for the possibility of modulating the ROS balance by magneto–thermal stimulation in the invertebrate model organism Hydra vulgaris, able to fully regenerate. By evaluating the expression of selected genes involved in the maintenance of ROS homeostasis and proliferation pathways, a biphasic modulation of the ROS levels played by the MNPs is found. While MNPs with a lower Mn2+ content are able to positively modulate the regeneration potential under magnetostimulation, MNPs with a higher Mn2+ content cause a different redox imbalance, negatively affecting the regeneration dynamic. This innovative approach reveals a novel way of manipulating redox homeostasis that can advance in the field of tissue engineering. [ABSTRACT FROM AUTHOR]

Advancing therapeutic effectiveness through the strategic co‐delivery of drugs in a sequential manner represents a compelling strategy. However, achieving precise and selective release of chemotherapeutic agents remains a formidable challenge. In this study, a co‐assembled Arginine‐Glycine‐Aspartate (RGD)‐functionalized dehydropeptide‐based gel loaded with magnetic liposomes and mesoporous silica‐coated gold nanorods is introduced. This composite system serves as a sophisticated tool to independently modulate the release of doxorubicin and methotrexate. The gel's properties are intricately tuned by the incorporation of liposomes or nanorods and/or the co‐assembly with an RGD‐functionalized peptide. Furthermore, the combined effects of sequential drug release, photothermia, and magnetic hyperthermia synergistically enhance therapeutic efficacy against 3D cancer cell cultures. Noteworthy attributes of the gel include its ability to orthogonally trigger loaded drugs, along with features such as injectability, rapid gelation, self‐healing, and mechanical properties suitable for drug delivery. Consequently, this versatile multimodal platform emerges as a promising option for therapeutic applications, particularly in the context of cancer therapy. [ABSTRACT FROM AUTHOR]

Glioblastoma multiforme (GBM) represents one of the most critical oncological diseases in neurological practice, being considered highly aggressive with a dismal prognosis. At a worldwide level, new therapeutic methods are continuously being researched. Magnetic hyperthermia (MHT) has been investigated for more than 30 years as a solution used as a single therapy or combined with others for glioma tumor assessment in preclinical and clinical studies. It is based on magnetic nanoparticles (MNPs) that are injected into the tumor, and, under the effect of an external alternating magnetic field, they produce heat with temperatures higher than 42 °C, which determines cancer cell death. It is well known that iron oxide nanoparticles have received FDA approval for anemia treatment and to be used as contrast substances in the medical imagining domain. Today, energetic, efficient MNPs are developed that are especially dedicated to MHT treatments. In this review, the subject's importance will be emphasized by specifying the number of patients with cancer worldwide, presenting the main features of GBM, and detailing the physical theory accompanying the MHT treatment. Then, synthesis routes for thermally efficient MNP manufacturing, strategies adopted in practice for increasing MHT heat performance, and significant in vitro and in vivo studies are presented. This review paper also includes combined cancer therapies, the main reasons for using these approaches with MHT, and important clinical studies on human subjects found in the literature. This review ends by describing the most critical challenges associated with MHT and future perspectives. It is concluded that MHT can be successfully and regularly applied as a treatment for GBM if specific improvements are made. [ABSTRACT FROM AUTHOR]

Superparamagnetic nanoparticles (SPMNPs) have attracted considerable attention in biomedicine, particularly magnetic hyperthermia for cancer treatment. However, the development of efficient and eco-friendly methods for synthesizing SPMNPs remains a challenge. This study reports on a green synthesis approach for SPMNPs using pomegranate peel extract as a stabilizing agent. The effects of various synthesis parameters, including the type of precipitating agent (NH3 and NaOH), N2 gas, extract volume, and pH, were systematically investigated with regard to the size, morphology, and magnetic properties of the nanoparticles. The results showed that reducing the volume of the extract increased the saturation magnetization of the nanoparticles. N2 gas was found to be essential in preventing the oxidation of the nanoparticles. The type of precipitating agent also affected the size and magnetization of the nanoparticles, with NaOH leading to the synthesis of SPMNPs with higher magnetization (~4 times) compared to NH3. Additionally, nanoparticles synthesized at pH 10 exhibited higher magnetization than those synthesized at pH 8 and 12. In conclusion, the optimized synthesis conditions significantly affected the magnetization and stability of SPMNPs. These nanoparticles are suitable for use in magnetic nanofluid hyperthermia applications. [ABSTRACT FROM AUTHOR]

By the example of α-Fe2O3 hematite, 5Fe2O3⋅9H2O ferrihydrite, and γ-Fe2O3 maghemite powders, a microwave-radiation-induced powder system temperature growth ΔTmax of several degrees has been measured in the ferromagnetic resonance mode at a frequency of 8.9 GHz. The powders heat up the most in the external field H coinciding with the ferromagnetic resonance field. The value of the ΔTmax effect depends on the magnetization of a powder material. The results obtained allow us to propose a new magnetic hyperthermia method for biomedical applications. [ABSTRACT FROM AUTHOR]

We investigate the thermal generation and transport properties of an assembly of magnetic nanoparticles embedded in a solid or fluid matrix, subjected to an AC magnetic field. For this purpose, we first build the heat equation for the assembly using the effective thermal transport coefficients obtained within the effective medium approach. In the present calculation, the SAR is obtained from the (linear) dynamic response of the assembly to the AC magnetic field. We numerically solve the extended heat equation and, as a preliminary study, we obtain the space-time profile of the temperature and total power absorbed by the system. [ABSTRACT FROM AUTHOR]

The pervasiveness of cancer is a global health concern posing a major threat in terms of mortality and incidence rates. Magnetic hyperthermia (MHT) employing biocompatible magnetic nanoparticles (MNPs) ensuring selective attachment to target sites, better colloidal stability and conserving nearby healthy tissues has garnered widespread acceptance as a promising clinical treatment for cancer cell death. In this direction, multifunctional iron oxide nanoparticles (IONPs) are of significant interest for improved cancer care due to finite size effect associated with inherent magnetic properties. This review offers a comprehensive perception of IONPs-mediated MHT from fundamentals to clinical translation, by elucidating the underlying mechanism of heat generation and the related influential factors. Biological mechanisms underlying MHT-mediated cancer cell death such as reactive oxygen species generation and lysosomal membrane permeabilization have been discussed in this review. Recent advances in biological interactions (in vitro and in vivo) of IONPs and their translation to clinical MHT applications are briefed. New frontiers and prospects of promising combination cancer therapies such as MHT with photothermal therapy, cancer starvation therapy and sonodynamic therapy are presented in detail. Finally, this review concludes by addressing current crucial challenges and proposing possible solutions to achieve clinical success.

AbstractObjective To investigate the potential of hybrid Pd/Fe-oxide magnetic nanoparticles designed for thermo-brachytherapy of breast cancer, considering their specific loss power (SLP) and clinical constraints in the applied magnetic field.Methods Hybrid nanoparticles consisting of palladium-core and iron oxide shell of increasing thickness, were suspended in water and their SLPs were measured at varying magnetic fields (12–26 mT peak) and frequencies (50–730 kHz) with a commercial alternating magnetic field generator (magneTherm™ Digital, nanoTherics Ltd.).Results Validation of the heating device used in this study with commercial HyperMag-C nanoparticles showed a small deviation (±4%) over a period of 1 year, confirming the reliability of the method. The integration of dual thermometers, one in the center and one at the bottom of the sample vial, allowed monitoring of homogeneity of the sample suspensions. SLPs measurements on a series of nanoparticles of increasing sizes showed the highest heating for the diameter of 21 nm (SLP = 225 W/g) at the applied frequencies of 346 and 730 kHz. No heating was observed for the nanoparticles with the size

Abstract An exciting prospect in the field of magnetic fluid hyperthermia (MFH) has been the integration of noble rare earth elements (Eu) with biopolymers (chitosan/dextran) that have optimum structures to tune specific effects on magnetic nanoparticles (NPs). However, the heating efficiency of MNPs is primarily influenced by their magnetization, size distribution, magnetic anisotropy, dipolar interaction, amplitude, and frequency of the applied field, the MNPs with high heating efficiency are still challenging. In this study, a comprehensive experimental analysis has been conducted on single-domain magnetic nanoparticles (SDMNPs) for evaluating effective anisotropy, assessing the impact of particle-intrinsic factors and experimental conditions on self-heating efficiency in both noninteracting and interacting systems, with a particular focus on the dipolar interaction effect. The study successfully reconciles conflicting findings on the interaction effects in the agglomeration and less agglomerated arrangements for MFH applications. The results suggest that effective control of dipolar interactions can be achieved by encapsulating Chitosan/Dextran in the synthesized MNPs. The lower dipolar interactions successfully tune the self-heating efficiency and hold promise as potential candidates for MFH applications.

The goal of this study is to investigate the fluid dynamics of a pseudoplastic Williamson nanofluid model, explicitly focusing on blood infused with magnetite (Fe2O3) and (Cu) copper nanoparticles, with the aim of enhancing its physiological and industrial applications. This research offers a novel approach by integrating the Williamson fluid model with magnetic nanoparticles, which has not been widely explored in biomedical applications like antitumor therapy and magnetic hyperthermia. The study is mathematically modeled using partial differential equations (PDEs) accounting for the deformation vortices of a stretching surface. These governing equations are transformed into ordinary differential equations (ODEs) via similarity transformations and solved numerically using the Runge-Kutta (R-K) 4th-order method coupled with the shooting technique. The velocity and temperature fields are then analyzed through MATLAB simulations. Results indicate that increasing the Williamson, radiation, and nanoparticle volume fraction parameters elevates the fluid temperature, whereas higher magnetic field strength, Prandtl number, and stretching parameter values reduce it. The novelty of this work lies in its application of the Williamson nanofluid model to real-time medical applications, such as cancer treatment through magnetic hyperthermia, and its potential use in advanced biomedical devices.

There is a continuous vivid search for biocompatible hybrid magneto-optical nanoprobes with high heating and photoluminescence efficiencies for photothermal theranostics. Herein, two tailored multipurpose hybrid PEGylated gold (Au) and silver sulfide (Ag2S) magnetic iron oxide nanoparticle formulations (Au-PEG-MNPs and Ag2S-PEG-MNPs) with unique opto-magnetic properties for simultaneous photothermal therapy were prepared. The physiochemical properties of the hybrid MNPs were fully characterized using various electronic and spectroscopic techniques, showing colloidal stabilized small-sized nanoparticles (core sizes = 10 nm, DH = 200 nm) with high saturation magnetizations (Ms up to 85 emu/g) and superparamagnetic behavior. Thermal effects in response to an alternating magnetic field (AMF) at different frequencies (f = 25–300 kHz) and field intensities (H = 12 and 24 kA/m) were assessed using an ultrafast magnetometric method, revealing high heating efficiencies with distinctive heating responses. The "optothermal" efficacies were then evaluated using a unique experimental setup equipped with a highly sensitive thermal camera for recording temperatures in real time, along with a simultaneous clinically safe near-infrared (NIR) laser (λ = 808 nm and power = 0.5 W cm–2) and AMF (H = 12 kA/m, f = 180 kHz) dual effect. Remarkably, when irradiated with an NIR laser and AMF, both hybrid Au- and Ag2S-PEG-MNPs displayed superior heat induction power (SAR = 384 and 441 W/g), rapidly reaching hyperthermia temperatures of 42 °C in only a few seconds. Temperatures could reach up to 75 °C for Au-PEG-MNPs and 90 °C for Ag2S-PEG-MNPs in only 5 min. Such superior heating efficiencies for the hybrid MNPs increased ∼1.5–2 times under concurrent irradiation compared to the action by laser alone. Finally, cytotoxicity assays against cancerous and normal cells confirmed the safety profiles and low toxicities of the hybrid nanoformulations. This unique synergistic platform has great potential to be utilized for multimodal photothermal therapy with reduced field strengths, laser intensities, and short irradiation times in the unceasing search for tangible hyperthermal clinical nanoprobes. [ABSTRACT FROM AUTHOR]

Cancer is a major worldwide public health problem. Although there have already been astonishing advances in cancer diagnosis and treatment, the scientific community continues to make huge efforts to develop new methods to treat cancer. The main objective of this work is to prepare, using a green sol–gel method with coconut water powder (CWP), a new nanocomposite with a mixture of Gd3Fe5O12 and ZnFe2O4, which has never been synthesized previously. Therefore, we carried out a structural (DTA-TG and X-ray diffraction), morphological (SEM), and magnetic (VSM and hyperthermia) characterization of the prepared samples. The prepared nanocomposite denoted a saturation magnetization of 11.56 emu/g at room temperature with a ferromagnetic behavior and with a specific absorption rate (SAR) value of 0.5 ± 0.2 (W/g). Regarding cytotoxicity, for concentrations < 10 mg/mL, it does not appear to be toxic. Although the obtained results were interesting, the high particle size was identified as a problem for the use of this nanocomposite. [ABSTRACT FROM AUTHOR]

Magnetic particle hyperthermia (MPH) enables the direct heating of solid tumors with alternating magnetic fields (AMFs). One challenge with MPH is the unknown particle distribution in tissue after injection. Magnetic particle imaging (MPI) can measure the nanoparticle content and distribution in tissue after delivery. The objective of this study was to develop a clinically translatable protocol that incorporates MPI data into finite element calculations for simulating tissue temperatures during MPH. To verify the protocol, we conducted MPH experiments in tumor-bearing mouse cadavers. Five 8–10-week-old female BALB/c mice bearing subcutaneous 4T1 tumors were anesthetized and received intratumor injections of Synomag®-S90 nanoparticles. Immediately following injection, the mice were euthanized and imaged, and the tumors were heated with an AMF. We used the Mimics Innovation Suite to create a 3D mesh of the tumor from micro-computerized tomography data and spatial index MPI to generate a scaled heating function for the heat transfer calculations. The processed imaging data were incorporated into a finite element solver, COMSOL Multiphysics®. The upper and lower bounds of the simulated tumor temperatures for all five cadavers demonstrated agreement with the experimental temperature measurements, thus verifying the protocol. These results demonstrate the utility of MPI to guide predictive thermal calculations for MPH treatment planning. [ABSTRACT FROM AUTHOR]

The challenges associated with the assessment of immune checkpoint inhibitor (ICI) therapy and low immunotherapy response observed in patients with poorly immunogenic tumors are addressed. A smart‐responsive nanoprobe MZF@Gd is synthetized based on magnetic resonance tuning (MRET). The nanoprobe is designed to be targeted and cleaved by granzyme B, a marker of cytotoxic T‐cell activation. MZF@Gd consisted of superparamagnetic Mn‐ and Zn‐doped ferrite magnetic nanoparticles (MZF‐MNPs) with a magnetocaloric effect and a paramagnetic contrast agent gadolinium‐diethylenetriamine penta‐acetic acid (Gd‐DTPA). These components are connected by the granzyme B substrate peptides. The activation of the T1WI signal through MRET, following the cleavage of the probe by granzyme B, enabled the accurate evaluation of the ICI therapeutic effect. Subsequently, an active‐targeting magnetothermally responsive nanotheranostic agent FA‐P(MZF@Gd/JQ1) is fabricated. This agent incorporated the MRET probe MZF@Gd, JQ‐1 (an inhibitor of PD‐L1), the thermosensitive copolymer PCL‐b‐P(MEO2MA‐co‐OEGMA), and folic acid on the surface. Nanotheranostic agents killed tumor cells through magnetocaloric effects, stimulated antitumor immunity, and regulated the drug release, thereby achieving a synergistic effect between hyperthermia and immunotherapy. Moreover, MZF@Gd released from the agent sensitively detected the presence of granzyme B at the tumor site, thereby enabling an effective assessment of therapeutic efficacy. [ABSTRACT FROM AUTHOR]

The preparation of manganese substituted iron oxide magnetic nanoparticles by polyol synthesis route. Due to the unique properties, diethylene glycol (DEG) and tri-ethylene glycol (TEG) used as a solvent in synthesis method with different volumetric variations. The structural, morphological and hyperthermic properties of prepared samples are investigated. Formation of single-phase cubic spinel lattice for all compositions confirmed by X-ray diffraction and crystallite size was found to be decreased from 20.6 ± 1.3 to 15.2 ± 1.7 nm with varying ratio of DEG/TEG. Transmission electron microscopy (TEM) analysis displayed spherical grains with an agglomeration of the MnFe2O4 magnetic nanoparticles (MNPs). Heating ability of MNPs studied with an induction heating system under different magnetic field strengths at 20 kA/m and 26.6 kA/m by varying nanoparticle concentrations at fixed frequency of 278 kHz. Antimicrobial activity on E. coli and antifungal activity on C. albicans showed effectiveness of MNPs at 10 mg/mL for such activities. Additionally, ROS induction in presence of MNPs illustrates probable action against E. coli and C. albicans and as antibacterial and antifungal agent in the medical field due to ROS generation ability.It has been shown that these optimized MNPs will play multifaceted roles for magnetic hyperthermia therapy as heat mediators, and antibacterial/antifungal agents owing to their magnetic induction heating properties and biological activities. [ABSTRACT FROM AUTHOR]

The magnetization reversal kinetics has been theoretically considered for a nanosized ferromagnetic particle in a soft viscoelastic medium. In contrast to well-known works, we have considered the simultaneous action of the Néel mechanism of magnetization reversal of a particle (overcoming the potential barrier of magnetic anisotropy by its magnetic moment), and rotation (turn) of the particle body as a result of a change in the external magnetic field. The case of a high magnetic anisotropy of the particle is considered, i.e., it has been assumed that its energy significantly exceeds the thermal energy of the system and the energy of the interaction between the particle and the magnetic field. No other limitations have been imposed on field strength. The case of low fields has been considered in greater detail in the linear approximation of the dependence of magnetization on the field. The components of the complex susceptibility of the composite are calculated within the framework of this approximation. It has been shown that the real component of the susceptibility decreases monotonically with the field frequency. If the stiffness of the composite is high or low, the imaginary component has one maximum, which corresponds to the Néel mechanism of magnetization reversal or particle rotation in a viscoelastic medium, respectively. At intermediate values of composite stiffness, the frequency dependence of the imaginary susceptibility has two maxima. [ABSTRACT FROM AUTHOR]

Cancer cells have higher heat sensitivity compared to normal cells; therefore, hyperthermia is a promising approach for cancer therapy because of its ability to selectively kill cancer cells by heating them. However, the specific and rapid heating of tumor tissues remains challenging. This study investigated the potential of magnetic nanoparticles (MNPs) modified with tumor-homing peptides (THPs), specifically PL1 and PL3, for tumor-specific magnetic hyperthermia therapy. The synthesis of THP-modified MNPs involved the attachment of PL1 and PL3 peptides to the surface of the MNPs, which facilitated enhanced tumor cell binding and internalization. Cell specificity studies revealed an increased uptake of PL1- and PL3-MNPs by tumor cells compared to unmodified MNPs, indicating their potential for targeted delivery. In vitro hyperthermia experiments demonstrated the efficacy of PL3-MNPs in inducing tumor cell death when exposed to an alternating magnetic field (AMF). Even without exposure to an AMF, an additional ferroptotic pathway was suggested to be mediated by the nanoparticles. Thus, this study suggests that THP-modified MNPs, particularly PL3-MNPs, hold promise as a targeted approach for tumor-specific magnetic hyperthermia therapy. [ABSTRACT FROM AUTHOR]

Endometriosis, an incurable gynecological disease that causes abnormal growth of uterine-like tissue outside the uterine cavity, leads to pelvic pain and infertility in millions of individuals. Endometriosis can be treated with medicine and surgery, but recurrence and comorbidities impair quality of life. In recent years, nanoparticle (NP)-based therapy has drawn global attention, notably in medicine. Studies have shown that NPs could revolutionize conventional therapeutics and imaging. Researchers aim to enhance the prognosis of endometriosis patients with less invasive and more effective NP-based treatments. This study evaluates this potential paradigm shift in endometriosis management, exploring NP-based systems for improved treatments and diagnostics. Insights into nanotechnology applications, including gene therapy, photothermal therapy, immunotherapy, and magnetic hyperthermia, offering a theoretical reference for the clinical use of nanotechnology in endometriosis treatment, are discussed in this review. [ABSTRACT FROM AUTHOR]

Tailoring the magnetic properties of iron oxide nanosystems is essential to expanding their biomedical applications. In this study, 34 nm iron oxide nanocubes with two phases consisting of Fe3O4 and α-Fe2O3 were annealed for 2 h in the presence of O2, N2, He, and Ar to tune the respective phase volume fractions and control their magnetic properties. X-ray diffraction and magnetic measurements were carried out post-treatment to evaluate changes in the treated samples compared to the as-prepared samples, showing an enhancement of the α-Fe2O3 phase in the samples annealed with O2 while the others indicated a Fe3O4 enhancement. Furthermore, the latter samples indicated enhancements in crystallinity and saturation magnetization, while coercivity enhancements were the most significant in samples annealed with O2, resulting in the highest specific absorption rates (of up to 1000 W/g) in all the applied fields of 800, 600, and 400 Oe in agar during magnetic hyperthermia measurements. The general enhancement of the specific absorption rate post-annealing underscores the importance of the annealing atmosphere in the enhancement of the magnetic and structural properties of nanostructures. [ABSTRACT FROM AUTHOR]

Currently, one of the main causes of death in the world is cancer; therefore, it is urgent to obtain a precocious diagnosis, as well as boost research and development of new potential treatments, which should be more efficient and much less invasive for the patient. Magnetic hyperthermia (MH) is an emerging cancer therapy using nanoparticles, which has proved to be effective when combined with chemotherapy, radiotherapy and/or surgery, or even by itself, depending on the type and location of the tumor's cells. This article presents the results obtained by using a previously developed economic homemade hyperthermia device with different types of magnetite nanoparticles, with sizes ranging between 12 ± 5 and 36 ± 11 nm and presenting different shapes (spherical and cubic particles). These magnetic nanoparticles (MNPs) were synthesized by three different methods (co-precipitation, solvothermal and hydrothermal processes), with their final form being naked, or possessing different kinds of covering layers (polyethylene glycol (PEG) or citric acid (CA)). The parameters used to characterize the heating by magnetic hyperthermia, namely the Specific Absorption Rate (SAR) and the intrinsic loss power (ILP), have been obtained by two different methods. Among other results, these experiments allowed for the determination of which synthesized MNPs showed the best performance concerning hyperthermia. From the results, it may be concluded that, as expected, the shape of MNPs is an important factor, as well as the time that the MNPs can remain suspended in solution (which is directly related to the concentration and covering layer of the MNPs). The MNPs that gave the best results in terms of the SAR were the cubic particles covered with PEG, while in terms of total heating the spherical particles covered with citric acid proved to be better. [ABSTRACT FROM AUTHOR]

A minimally invasive cancer treatment method utilizing magnetic nanoparticles (MNPs) and magnetic coils, magnetic hyperthermia, generates heat locally inside the body to degenerate cancer cells. The uniformity of the coil's magnetic field is a crucial factor in enhancing the therapeutic effect. In this study, we evaluated the temperature distribution of MNPs on induction heating experiments at various distances using two types of coils. We found that the 2‐turn coil with a larger outer diameter and higher magnetic field uniformity resulted in a treatment temperature region approximately twice as wide as the 4‐turn coil, indicating the enhancement of the treatment effect under the uniform magnetic field distributions. © 2024 Institute of Electrical Engineer of Japan and Wiley Periodicals LLC. [ABSTRACT FROM AUTHOR]

Ferromagnetic metallic cobalt and nickel nanoparticles were synthesized by intramolecular metal-hydrazine ligand oxidation reduction reaction in basic media and the solid state. Nickel nanoparticles Ni1 and Ni2 are obtained from two complexes, Ni(N2H4)2(C2O4) and Ni(N2H4)2(HCO2)2, respectively. X-ray powder diffraction (XRD) and energy-dispersive X-ray (EDX) data show pure fcc crystal structures of nanoparticles. Scanning electron microscopy (SEM) images revealed both Ni1 and Ni2 nanoparticles have agglomerated sphere morphologies. The crystallite size estimated by using the Scherer method for Ni1 and Ni2 were 18.7 and 6.2 nm. Vibrating sample magnetometer (VSM) data show the coercivity of metallic nickel samples Ni1 and Ni2 are 50 and 153 Oe, respectively. Both nanoparticles cause an increase in the temperature of water under applied alternative magnetic field and showed specific loss power (SLP) of 70 W/g and 104.8 W/g, respectively. The same method is used in preparation of cobalt nanoparticles from two complexes, Co(N2H4)2(C2O4) and Co(N2H4)2(HCO2)2. XRD analysis data show both nanoparticles have hcp crystal structure. SEM images show nanosheet structure with sheet thickness of 10 to 30 nm. Coercivity of Co1 and Co2 nanoparticles obtained by VSM and Hc are 182 and 171 Oe, respectively. In spite of high coercivity in both Co1 and Co2 nanoparticles, the magnetic hyperthermia heating effects are not observed in practice and specific loss power (SLP) is zero. [ABSTRACT FROM AUTHOR]

Here, we present the results of the synthesis, surface modification, and properties analysis of magnetite-based nanoparticles, specifically Co0.047Fe2.953O4 (S1) and Co0.086Fe2.914O4 (S2). These nanoparticles were synthesized using the co-precipitation method at 80 °C for 2 h. They exhibit a single-phase nature and crystallize in a spinel-type structure (space group Fd 3 ¯ m). Transmission electron microscopy analysis reveals that the particles are quasi-spherical in shape and approximately 11 nm in size. An observed increase in saturation magnetization, coercivity, remanence, and blocking temperature in S2 compared to S1 can be attributed to an increase in magnetocrystalline anisotropy due to the incorporation of Co ions in the crystal lattice of the parent compound (Fe3O4). The heating efficiency of the samples was determined by fitting the Box-Lucas equation to the acquired temperature curves. The calculated Specific Loss Power (SLP) values were 46 W/g and 23 W/g (under HAC = 200 Oe and f = 252 kHz) for S1 and S2, respectively. Additionally, sample S1 was coated with citric acid (Co0.047Fe2.953O4@CA) and poly(acrylic acid) (Co0.047Fe2.953O4@PAA) to obtain stable colloids for further tests for magnetic hyperthermia applications in cancer therapy. Fits of the Box-Lucas equation provided SLP values of 21 W/g and 34 W/g for CA- and PAA-coated samples, respectively. On the other hand, X-ray photoelectron spectroscopy analysis points to the catalytically active centers Fe2+/Fe3+ and Co2+/Co3+ on the particle surface, suggesting possible applications of the samples as heterogeneous self-heating catalysts in advanced oxidation processes under an AC magnetic field. [ABSTRACT FROM AUTHOR]

An exciting prospect in the field of magnetic fluid hyperthermia (MFH) has been the integration of noble rare earth elements (Eu) with biopolymers (chitosan/dextran) that have optimum structures to tune specific effects on magnetic nanoparticles (NPs). However, the heating efficiency of MNPs is primarily influenced by their magnetization, size distribution, magnetic anisotropy, dipolar interaction, amplitude, and frequency of the applied field, the MNPs with high heating efficiency are still challenging. In this study, a comprehensive experimental analysis has been conducted on single-domain magnetic nanoparticles (SDMNPs) for evaluating effective anisotropy, assessing the impact of particle-intrinsic factors and experimental conditions on self-heating efficiency in both noninteracting and interacting systems, with a particular focus on the dipolar interaction effect. The study successfully reconciles conflicting findings on the interaction effects in the agglomeration and less agglomerated arrangements for MFH applications. The results suggest that effective control of dipolar interactions can be achieved by encapsulating Chitosan/Dextran in the synthesized MNPs. The lower dipolar interactions successfully tune the self-heating efficiency and hold promise as potential candidates for MFH applications. [ABSTRACT FROM AUTHOR]

The anticancer and antibacterial potential of magnetite (Fe3O4) nanoparticles have been investigated using different biological assays. Also, an induction heating study was performed to check the magnetic hyperthermia application of synthesized Fe3O4 nanoparticles. An antimicrobial study was performed against gram-positive and gram-negative bacterial strains. Among them, the Staphylococcus aureus bacterial strain showed maximum antimicrobial activity with a 15 mm zone of inhibition for 500 µg/mL of Fe3O4 nanoparticles. The antioxidant activity was ascertained through a DPPH (1, 1-diphenyl-2, picryl-hydrazyl) assay. Fe3O4 nanoparticles showed 30.57% free radical scavenging activity due to its antioxidative nature. The anticancer potential of Fe3O4 nanoparticles was evaluated against the breast cancer (MDA-MB-231) cell lines and fibroblast (L929) cell line using 3-(4, 5-dimethythiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) cytotoxicity assay. Fe3O4 nanoparticles proved to be toxic to the MDA-MB-231 cell line even at a concentration of 3.125 µg mL−1, and an increase in cytotoxicity to 89% from 20% was observed with the rise in Fe3O4 nanoparticles concentration to 100 µg mL−1. The observed cytotoxicity for the L929 cell line is low revealing the biocompatible nature of synthesized Fe3O4 nanoparticles. Also, the biocompatibility for invitro application was examined using angiogenesis activity which does not show any antiangiogenics activity of synthesized Fe3O4 nanoparticles. Additionally, the inductive heating characteristic of Fe3O4 nanoparticles in an alternating current (AC) magnetic field was examined at a frequency of 278 kHz, and for the different magnetic fields of 13.3, 20.0, and 26.7 kA m−1 for 600 s with different suspension concentrations of Fe3O4 nanoparticles as 0.5, 1.0, 2.0, 3.0, and 5.0 mg mL−1. The highest rise in temperature of 60.63 °C was observed for 5 mg mL−1 at a magnetic field of 26.7 kA m−1 with a specific absorption rate (SAR) value of 85 Wg−1 which makes them suitable for hyperthermia application. The study shows promising antimicrobial, antioxidative, anticancer, and induction heating properties. Herein, the present study reveals the potential of Fe3O4 nanoparticles for improved therapeutic applications and effective bactericidal propensity. [ABSTRACT FROM AUTHOR]

Lymphatic metastasis is the main cause of early-stage tumor spread, making the identification and therapy of metastatic sentinel lymph nodes (SLNs) are highly desirable in clinic. Currently, suspected malignant SLNs typically undergo a series of independent operations in clinical practice, including imaging, staining, sentinel lymph node biopsy (SLNB) and lymph node dissection (LND), which brings inconvenience to diagnosis and treatment, and may cause postoperative complications for patients. Moreover, the ordinary removal of tumor-draining lymph nodes (TDLNs) may do harm to systemic immunity required for tumor eradication. Hence, we utilized the hybrid nanosystem (SPIOs + RPPs) we constructed before for the integrated staining, ultrasound imaging, and therapy of metastatic SLNs. In this study, SPIOs + RPPs could migrate into SLNs successfully to stain them black for easy visual identification. Beyond staining, the hybrid nanosystem could realize contrast enhanced ultrasound (CEUS) imaging in SLNs. Meanwhile, it could inhibit cancer cells to lower the tumor burden and reverse immune-suppressive microenvironment of metastatic SLNs effectively via magnetic hyperthermia immunotherapy in VX2 tumor-bearing rabbits with popliteal fossa lymph node metastasis. These findings indicate that SPIOs + RPPs is a potential multifunctional theranostic agent for detection and therapy of lymphatic metastasis.

Superparamagnetic nanoparticles (SPMNPs) have attracted considerable attention in biomedicine, particularly magnetic hyperthermia for cancer treatment. However, the development of efficient and eco-friendly methods for synthesizing SPMNPs remains a challenge. This study reports on a green synthesis approach for SPMNPs using pomegranate peel extract as a stabilizing agent. The effects of various synthesis parameters, including the type of precipitating agent (NH3 and NaOH), N2 gas, extract volume, and pH, were systematically investigated with regard to the size, morphology, and magnetic properties of the nanoparticles. The results showed that reducing the volume of the extract increased the saturation magnetization of the nanoparticles. N2 gas was found to be essential in preventing the oxidation of the nanoparticles. The type of precipitating agent also affected the size and magnetization of the nanoparticles, with NaOH leading to the synthesis of SPMNPs with higher magnetization (∼4 times) compared to NH3. Additionally, nanoparticles synthesized at pH 10 exhibited higher magnetization than those synthesized at pH 8 and 12. In conclusion, the optimized synthesis conditions significantly affected the magnetization and stability of SPMNPs. These nanoparticles are suitable for use in magnetic nanofluid hyperthermia applications.

Ana Cepero,1– 3,&ast; Mónica Jiménez-Carretero,4,&ast; Ylenia Jabalera,4 Lidia Gago,1– 3 Cristina Luque,1– 3 Laura Cabeza,1– 3 Consolación Melguizo,1– 3 Concepcion Jimenez-Lopez,4 José Prados1– 3 1Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, 18100, Spain; 2Department of Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, 18071, Spain; 3Biosanitary Research Institute ibs.GRANADA, Granada, 18012, Spain; 4Department of Microbiology, Sciences School, University of Granada, Granada, 18002, Spain&ast;These authors contributed equally to this workCorrespondence: Laura Cabeza; Concepción Jimenez-Lopez, Email lautea@ugr.es; cjl@ugr.esPurpose: The lack of specificity of conventional chemotherapy is one of the main difficulties to be solved in cancer therapy. Biomimetic magnetoliposomes are successful chemotherapy controlled-release systems, hyperthermia, and active targeting agents by functionalization of their surface with monoclonal antibodies. The membrane receptor Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) stands out as colorectal cancer (CRC) biomarker and appears to be related to treatment resistance and the development of metastasis. The aim of this study was to assess the effectiveness and safety of LGR5-targeted biomimetic magnetoliposomes loaded with oxaliplatin (OXA) or 5-fluorouracil (5-FU) in the selective treatment of CRC and their possible application in hyperthermia.Methods: Synthesis, characterization and determination of heating capacity of magnetoliposomes transporting OXA or 5-FU (with and without LGR5 functionalization) were conducted. In vitro antitumoral activity was assayed in multiple colorectal cell lines at different times of exposition. In addition to this, cell internalization was studied by Prussian Blue staining, flow cytometry and fluorescence microscopy. In vivo acute toxicity of magnetoliposomes was performed to evaluate iron-related toxicity.Results: OXA and 5-FU loaded magnetoliposomes functionalized with LGR5 antibody showed higher cellular uptake than non-targeted nanoformulation with a reduction of the percentage of proliferation in colon cancer cell lines up to 3.2-fold of the IC50 value compared to that of free drug. The differences between non-targeted and targeted nanoformulations were more evident after short exposure times (4 and 8 hours). Interestingly, assays in the MC38 transduced cells with reduced LGR5 expression (MC38-L(-)), showed lower cell internalization of LGR5-targeted magnetoliposomes compared to non-transduced MC38 cell line. In addition, magnetoliposomes showed an in vitro favorable heating response under magnetic excitation and great iron-related biocompatibility data in vivo.Conclusion: Drug-loaded magnetoliposomes functionalized with anti-LGR5 antibodies could be a promising CRC treatment strategy for LGR5+ targeted chemotherapy, magnetic hyperthermia, and both in combination. Keywords: colorectal neoplasms, magnetoliposome, LGR5, oxaliplatin, 5-fluorouracil, magnetic hyperthermia

This study aims to describe and evaluate the performance of a new device for magnetic hyperthermia that can produce an alternating magnetic field with adjustable frequency without the need to change capacitors from the resonant bank, as required by other commercial devices. This innovation, among others, is based on using a capacitator bank that dynamically adjusts the frequency. To validate the novel system, a series of experiments were conducted using commercial magnetic nanoparticles (MNPs) demonstrating the device’s effectiveness and allowing us to identify new challenges associated with the design of more powerful devices. A computational model was also used to validate the device and to allow us to determine the best system configuration. The results obtained are consistent with those from other studies using the same MNPs but with magnetic hyperthermia commercial equipment, confirming the good performance of the developed device (e.g., consistent SAR values between 1.37 and 10.80 W/gMNP were obtained, and experiments reaching temperatures above 43 °C were also obtained). This equipment offers additional advantages, including being economical, user-friendly, and portable.

The present work investigates the effect of external alternating magnetic field (AMF) on the electrocatalytic activity of nickel (Ni), iron oxide magnetic nanoparticles (MNP), and Ni-MNP nanoparticles in the urea electro-oxidation reaction (UER) through chronoamperometry (CA) with amplitudes of AMF between 14.9 and 88.9 mT and a frequency of 224 kHz. Results indicate that the AMF between 29.8 and 88.9 mT had a significant impact on the efficiency of UER, increasing the current obtained from Ni-MNP nanoparticles supported on carbon cloth (Ni-MNP/CC) by up to 52.5%. Moreover, a linear relationship between the UER current and AMF amplitude was observed. The significant enhancement of the current in the UER process with Ni-MNP/CC as catalyst under the AMF is attributed to the local heat generated by MNP nanoparticles, boosting the UER process on nickel nanoparticles. This work represents the first investigation of AMF on the UER process. [Display omitted] • Urea electro-oxidation was enhanced under an external alternating magnetic field. • Magnetic hyperthermia shows to be a suitable strategy to boot urea electro-oxidation. • Iron oxide magnetic nanoparticles produce heat under an alternating magnetic field. • The heat produced nearby to the nickel particles enhances the urea electro-oxidation. [ABSTRACT FROM AUTHOR]

Four samples containing magnetic iron oxide nanoparticles (MIONs) of various sizes are prepared employing a simple low-temperature method of oxidative precipitation from FeCl2∙4H2O–NaOH–NaNO3 aqueous solution. For the preparation of two samples, the usual oxidation-precipitation synthesis protocol is modified by using ethylenediaminetetraacetic acid (EDTA) chelating agent as a stabilizer of the Fe2+ ions in a solution, which results in the partial capping of the prepared MIONs with EDTA molecules. Three out of four samples are subjected to citric acid (CA) functionalization in the post synthesis protocol. Structural and magnetic properties of the synthesized MIONs are assessed using various experimental techniques (XRD, TEM, Fourier transform infrared, dynamic light scattering, Mössbauer, and SQUID). The average size of spherical-like MIONs is tuned from 7 nm to 38 nm by changing the synthesis protocol. Their room temperature saturation magnetization, M s, is in the range of 43 to 91 emu g−1. Magnetic heating ability, expressed via specific absorption rate value, which ranges from 139 to 390 W/gFe, is discussed in relation to their structural and magnetic properties and the possible energy dissipation mechanisms involved. The best heating performance is exhibited by the sample decorated with EDTA and with a bimodal size distribution with average particle sizes of 14 and 37 nm and M s = 87 emu g−1. Though this sample contains particles prone to form aggregates, capping with EDTA provides good colloidal stability of this sample, thus preserving the magnetic heating ability. It is demonstrated that two samples, consisting of 7 nm-sized CA- or 14 nm-sized EDTA/CA-functionalized superparamagnetic MIONs, with a similar hydrodynamic radius, heat in a very similar way in the relatively fast oscillating alternating current magnetic field, f = 577 kHz. [ABSTRACT FROM AUTHOR]